Generation of Effector Memory T Cell–Based Mucosal and Systemic Immunity with Pulmonary Nanoparticle Vaccination
Open Access
- 25 September 2013
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 5 (204) , 204ra130
Abstract
A lipid nanocapsule vaccine promotes cross-presentation of antigen with enhanced draining lymph node delivery to elicit an effector memory CD8 + T cell response.Keywords
This publication has 41 references indexed in Scilit:
- A vaccine strategy that protects against genital herpes by establishing local memory T cellsNature, 2012
- Spatiotemporally separated antigen uptake by alveolar dendritic cells and airway presentation to T cells in the lungJournal of Experimental Medicine, 2012
- Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentationProceedings of the National Academy of Sciences, 2012
- Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand T fh cells and promote germinal center inductionProceedings of the National Academy of Sciences, 2012
- Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humansJournal of Experimental Medicine, 2011
- Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccinationProceedings of the National Academy of Sciences, 2011
- Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responsesNature Materials, 2011
- Efficient Generation of Mucosal and Systemic Antigen-Specific CD8+T-Cell Responses following Pulmonary DNA ImmunizationJournal of Virology, 2010
- Memory CD8+ T cell differentiationAnnals of the New York Academy of Sciences, 2010
- Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinaseNature Protocols, 2009